Other gene targets with genetic alterations in lung cancer include human epidermal growth factor receptor (HER2), Mitogen-activated protein kinase (MEK), Anaplastic lymphoma kinase (ALK), (ROS1) and Fibroblast growth factor receptor 1 (FGFR1) (14–17). Here, FGFR1 is linked to lung carcinoma.